As a central component of the complement system, C3 protein has been identified as a plasma biomarker of brain atrophy in Alzheimer's disease.[43] In this study, we found that C3 protein was downregulated in EVs from r‐DMV participants compared with the c‐DMV group. This evidence concerns the gene C3 and early-onset autosomal dominant Alzheimer disease.